As the life sciences sector grapples with a rapidly changing environment and increasing regulatory scrutiny, Frits Stulp of Iperion – a Deloitte business, predicts that harnessing the power of digital transformation can optimise patient outcomes.
At a time of global focus on getting drug and vaccines to market quickly and safely, 2021 looks set to be the year when the potential of IDMP is realised.
